CVS Health Corporation
CVS Health Corporation (CVS) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CVS · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
10
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
CVS Health Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
CVS insider buying and selling by quarter
CVS insider selling · CVS insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · CVS ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CVS executive sell shares · CVS board member insider trading · CVS insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 31, 2026 | Newman Brian EVP, Chief Financial Officer | Other | 2,478 | $225K | Form 4 |
| May 31, 2026 | Compton-Phillips Amy EVP, Chief Medical Officer | Other | 7,618 | $693K | Form 4 |
| May 20, 2026 | AGUIRRE FERNANDO Director | Other | 30,437 | $2.85M⚡ | Form 4 |
| May 21, 2026 | AGUIRRE FERNANDO Director | Other | 1,563 | $146K | Form 4 |
| May 19, 2026 | ROBBINS LARRY Director | Sale | 1,983,387 | $187.33M⚡ | Form 4 |
| May 19, 2026 | ROBBINS LARRY Director | Sale | 151 | $14K | Form 4 |
| May 20, 2026 | ROBBINS LARRY Director | Sale | 797,628 | $74.56M⚡ | Form 4 |
| May 20, 2026 | ROBBINS LARRY Director | Sale | 152,691 | $14.48M⚡ | Form 4 |
| May 20, 2026 | ROBBINS LARRY Director | Sale | 66,881 | $6.40M⚡ | Form 4 |
| May 20, 2026 | ROBBINS LARRY Director | Sale | 800 | $77K | Form 4 |
| May 21, 2026 | ROBBINS LARRY Director | Sale | 370,462 | $34.62M⚡ | Form 4 |
| May 14, 2026 | AGUIRRE FERNANDO Director | Award | 1,563 | $152K | Form 4 |
| May 14, 2026 | Balser Jeffrey R. Director | Award | 2,058 | $200K | Form 4 |
| May 14, 2026 | KIRBY J SCOTT Director | Award | 1,447 | $141K | Form 4 |
| May 14, 2026 | Norwalk Leslie V Director | Award | 1,447 | $141K | Form 4 |
| May 14, 2026 | SANSONE GUY P Director | Award | 1,447 | $141K | Form 4 |
| May 14, 2026 | BROWN C DAVID II Director | Award | 1,544 | $150K | Form 4 |
| May 8, 2026 | Mandadi Tilak EVP, Chief Exp & Tech Officer | Sale | 69,551 | $6.23M⚡ | Form 4 |
| Apr 1, 2026 | Shah Prem S EVP and Group President | Other | 1,484 | $108K | Form 4 |
| Apr 1, 2026 | Nelson Steven H EVP and President, Aetna | Other | 2,432 | $176K | Form 4 |
| Apr 1, 2026 | Mandadi Tilak EVP, Chief Exp & Tech Officer | Other | 3,634 | $263K | Form 4 |
| Apr 1, 2026 | Khichi Samrat S. EVP, CPO and General Counsel | Other | 3,541 | $257K | Form 4 |
| Apr 1, 2026 | Joyner J. David President, CEO and Chair · Director | Other | 8,029 | $582K | Form 4 |
| Apr 1, 2026 | Clark James David SVP, Cont & Chief Acct Officer | Other | 3,262 | $236K | Form 4 |
| Apr 1, 2026 | CAPOZZI HEIDI B EVP and Chief People Officer | Other | 1,334 | $97K | Form 4 |
Newman Brian
EVP, Chief Financial Officer
Date
May 31
Shares
2,478
Price
$90.98
Value
$225K
Compton-Phillips Amy
EVP, Chief Medical Officer
Date
May 31
Shares
7,618
Price
$90.98
Value
$693K
Mandadi Tilak
EVP, Chief Exp & Tech Officer
Date
May 8
Shares
69,551
Price
$89.58
Value
$6.23M ⚡
Shah Prem S
EVP and Group President
Date
Apr 1
Shares
1,484
Price
$72.49
Value
$108K
Nelson Steven H
EVP and President, Aetna
Date
Apr 1
Shares
2,432
Price
$72.49
Value
$176K
Mandadi Tilak
EVP, Chief Exp & Tech Officer
Date
Apr 1
Shares
3,634
Price
$72.49
Value
$263K
Khichi Samrat S.
EVP, CPO and General Counsel
Date
Apr 1
Shares
3,541
Price
$72.49
Value
$257K
Joyner J. David
President, CEO and Chair · Director
Date
Apr 1
Shares
8,029
Price
$72.49
Value
$582K
Clark James David
SVP, Cont & Chief Acct Officer
Date
Apr 1
Shares
3,262
Price
$72.49
Value
$236K
CAPOZZI HEIDI B
EVP and Chief People Officer
Date
Apr 1
Shares
1,334
Price
$72.49
Value
$97K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CVS insider trading
CVS insider trades
CVS Health Corporation (CVS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ROBBINS LARRY (Director), AGUIRRE FERNANDO (Director), Mandadi Tilak (EVP, Chief Exp & Tech Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. CVS insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For CVS Health Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CVS insider trading · 5 questionsThe insiders of CVS Health Corporation (CVS) include executives and directors such as ROBBINS LARRY (Director), AGUIRRE FERNANDO (Director), Mandadi Tilak (EVP, Chief Exp & Tech Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026